| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.139.971 | 12.500.829 | 13.253.522 | 14.218.758 | 8.687.942 | 11.768.622 | 11.793.087 | 12.652.444 | 12.404.204 | 12.863.552 |
| Total Income - EUR | 9.272.656 | 12.724.361 | 13.381.816 | 14.386.710 | 8.844.330 | 12.009.651 | 11.952.623 | 13.030.579 | 12.851.749 | 13.156.262 |
| Total Expenses - EUR | 9.130.243 | 12.052.653 | 12.879.926 | 13.852.517 | 8.268.766 | 11.455.045 | 10.635.283 | 11.982.925 | 11.738.262 | 12.080.291 |
| Gross Profit/Loss - EUR | 142.412 | 671.708 | 501.890 | 534.193 | 575.563 | 554.606 | 1.317.340 | 1.047.654 | 1.113.487 | 1.075.971 |
| Net Profit/Loss - EUR | 134.991 | 588.009 | 400.170 | 405.956 | 422.938 | 485.745 | 1.146.079 | 921.053 | 971.167 | 927.877 |
| Employees | 42 | 47 | 43 | 44 | 44 | 47 | 55 | 59 | 64 | 63 |
Check the financial reports for the company - Bristol-Myers Squibb Marketing Services Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 75.177 | 176.299 | 117.074 | 73.039 | 96.494 | 87.624 | 101.486 | 559.321 | 526.259 | 413.925 |
| Current Assets | 4.636.026 | 6.152.519 | 6.804.886 | 7.530.601 | 7.439.506 | 5.321.443 | 7.103.262 | 7.466.416 | 8.562.922 | 4.486.987 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.509.158 | 6.070.934 | 6.731.330 | 7.365.260 | 7.394.138 | 5.270.694 | 7.040.522 | 7.390.403 | 8.515.641 | 4.438.412 |
| Cash | 126.867 | 81.585 | 73.556 | 165.341 | 45.368 | 50.749 | 62.740 | 76.013 | 47.282 | 48.574 |
| Shareholders Funds | 1.790.382 | 2.360.132 | 2.720.365 | 3.076.397 | 3.439.757 | 3.860.293 | 4.920.766 | 5.857.086 | 6.810.491 | 2.587.905 |
| Social Capital | 647.469 | 640.866 | 630.021 | 618.459 | 606.482 | 594.985 | 581.790 | 583.595 | 581.826 | 578.574 |
| Debts | 2.850.483 | 3.884.697 | 4.116.547 | 4.406.686 | 4.055.360 | 1.451.281 | 2.187.254 | 2.013.040 | 2.103.485 | 2.217.236 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7312 - 7312" | |||||||||
| CAEN Financial Year |
7312
|
|||||||||
Comments - Bristol-Myers Squibb Marketing Services Srl